New York, USA – November 8, 2021 – Bispecific antibodies (bsAbs) are designed to recognize two different epitopes and, compared to current monovalent antibody therapeutics, which have enhanced binding, specificity, and efficacy. These features make them exciting candidates for more targeted cancer treatments.
Being aware of the great potential of bsAbs, scientists at Creative Biolabs has long been focusing on bsAb development services and products and has established a portfolio of innovative platforms for bsAb developability assessment, sequencing, mimetics development, as well as bsAb-drug conjugate development and cell-free bsAb expression.
To promote the communication of the scientific community, Creative Biolabs has held a free-to-attend bsAb webinar series to reveal cutting-edge breakthroughs from researchers of repute. On October 14th, 2021, the webinar Harnessing the Power of Bispecific Antibodies has been successfully held with the brilliant talk and share from Dr. Archana Thakur and Dr. Luca Varani.
This webinar features a novel bsAb design with increased tumor-killing ability and an innovative bsAb molecule to fight against SARS-CoV-2.
Dr. Archana Thakur, the Associate Professor from School of Medicine, University of Virginia, introduced her team’s research of bsAb-armed metabolically-enhanced headless CAR T cells (hCART), and their enhanced ability to kill tumor targets, secrete cytokines and chemokines, and continue to kill under in vitro hypoxic condition.
Dr. Luca Varani, the Group Leader from Institute for Research in Biomedicine, showed his team’s design of a bispecific IgG1-like molecule (CoV-X2) and how it works in a mouse model of SARS-CoV-2 infection.
The webinar recording is available now online. Visitors can watch it freely simply by completing the form with the information requested. This information is required so that the Creative Biolabs team can keep you updated via email of any upcoming free webinars.
Please note that Creative Biolabs will not share this information with any third parties. You may choose to unsubscribe at any time by clicking on the “unsubscribe” link in any email communication from Creative Biolabs.
Please feel free to share the webinars with others. More information can be found at https://www.creative-biolabs.com/bsab.
About Creative Biolabs
Creative Biolabs has been dedicated to offering services on antibody discovery, engineering, production, and analysis for years. The bispecific antibody (bsAb) team has gathered a collective of experienced scientists committed to providing high-quality services to customers all over the world, covering bsAb design, purification, engineering, manufacturing and bsAb analysis service. With the cutting-edge platforms and methods, a comprehensive list of BsAb products is also available.